![How effective are medications to treat opioid use disorder? | National Institute on Drug Abuse (NIDA) How effective are medications to treat opioid use disorder? | National Institute on Drug Abuse (NIDA)](https://nida.nih.gov/sites/default/files/methadone_treatment.gif)
How effective are medications to treat opioid use disorder? | National Institute on Drug Abuse (NIDA)
![Effects of medication assisted treatment (MAT) for opioid use disorder on functional outcomes: A systematic review - Journal of Substance Abuse Treatment Effects of medication assisted treatment (MAT) for opioid use disorder on functional outcomes: A systematic review - Journal of Substance Abuse Treatment](https://www.journalofsubstanceabusetreatment.com/cms/asset/2ecb563d-5696-46f5-ae9a-7a8d426d6640/gr1.jpg)
Effects of medication assisted treatment (MAT) for opioid use disorder on functional outcomes: A systematic review - Journal of Substance Abuse Treatment
![Trends in the Use of Methadone, Buprenorphine, and Extended-release Naltrexone at Substance Abuse Treatment Facilities: 2003-2015 (Update) Trends in the Use of Methadone, Buprenorphine, and Extended-release Naltrexone at Substance Abuse Treatment Facilities: 2003-2015 (Update)](https://www.samhsa.gov/data//sites/default/files/report_3192/images/image_file_3184_BlockImageOne_1828247050.png)
Trends in the Use of Methadone, Buprenorphine, and Extended-release Naltrexone at Substance Abuse Treatment Facilities: 2003-2015 (Update)
![Innovation Spotlight: What are Medications for Addiction Treatment (MAT) for Opioid Use Disorder? - Center for Care Innovations Innovation Spotlight: What are Medications for Addiction Treatment (MAT) for Opioid Use Disorder? - Center for Care Innovations](https://www.careinnovations.org/wp-content/uploads/MAT_graph.png)
Innovation Spotlight: What are Medications for Addiction Treatment (MAT) for Opioid Use Disorder? - Center for Care Innovations
![Trends in the Use of Methadone, Buprenorphine, and Extended-release Naltrexone at Substance Abuse Treatment Facilities: 2003-2015 (Update) Trends in the Use of Methadone, Buprenorphine, and Extended-release Naltrexone at Substance Abuse Treatment Facilities: 2003-2015 (Update)](https://www.samhsa.gov/data//sites/default/files/report_3192/images/image_file_3178_BlockImageOne_593896626.png)